Pearl Therapeutics News

News on Pearl Therapeutics continually updated from thousands of sources around the net.

Monday May 21 | BioSpace

Pearl Therapeutics Receives TiE50 Award from Global Entrepreneurship Network

The TiE50 awards program recognizes the top technology startups from the following segments: internet, energy, wireless/mobile, software and life sciences.

Comment?

Fri Jan 06, 2012

Freshnews

Pearl Therapeutics Announces Successful Completion of Phase 2b Safety ...

Pearl Therapeutics Inc. today announced the completion of two Phase 2b clinical studies of PT003 , the Company's investigational inhaled combination bronchodilator product for the treatment of patients with moderate-to-severe COPD.

Comment?

Related Topix: Copd, Medicine, Foradil, Formoterol (generic)

Wed Dec 07, 2011

Drugs.com

Pearl Therapeutics Reports Positive Phase 2b Results of PT001 in Patients With COPD

REDWOOD CITY, Calif., Dec. 7, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. today announced positive top-line results from a randomized, double-blind, Phase 2b, dose-ranging study of glycopyrrolate, a long-acting muscarinic agonist delivered twice a day via metered-dose inhaler in patients with moderate-to-severe COPD.

Comment?

Fri Sep 02, 2011

Drugs.com

Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI

REDWOOD CITY, Calif., Aug. 30, 2011 /PRNewswire/ -- Pearl Therapeutics Inc. today announced positive results from a randomized, double-blind, Phase 2b, dose-ranging study of its formoterol fumarate metered dose inhaler , a long-acting beta-2 agonist compared to placebo and ForadilA AerolizerA in patients with moderate-to-severe COPD.

Comment?